Bhatia Sangeeta N.
SEC CIK 1643921 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | Dir | 4,924 | — | $3.42M | 24 | 2022-04-08 | 2026-05-04 |
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
| 13 | Bhatia Sangeeta N. | Dir | — | $267.7K |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-05 16:51 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +943 | 5,242 | +22% | $0 |
| T | 2026-05-05 16:51 | 2026-05-04 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $423.73 | -318 | 4,924 | -6% | -$134.7K |
| 2026-02-18 | 2026-02-13 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $500.00 | -266 | 4,299 | -6% | -$133.0K | |
| 2025-08-29 | 2025-08-27 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $386.69 | -266 | 4,565 | -6% | -$102.9K | |
| 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +796 | 5,231 | +18% | $0 | |
| 2025-05-05 | 2025-05-02 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $505.86 | -400 | 4,831 | -8% | -$202.3K | |
| D | 2024-09-04 | 2024-08-30 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale+OE | $500.00 | -646 | 4,435 | -13% | -$323.0K |
| D | 2024-09-04 | 2024-08-30 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | M - OptEx | $152.74 | +646 | 5,081 | +15% | +$98.7K |
| D | 2024-08-12 | 2024-08-08 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale+OE | $466.29 | -1,292 | 4,435 | -23% | -$602.4K |
| D | 2024-08-12 | 2024-08-08 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | M - OptEx | $152.74 | +1,292 | 5,727 | +29% | +$197.3K |
| 2024-05-03 | 2024-05-02 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $402.95 | -467 | 4,435 | -10% | -$188.2K | |
| 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +1,001 | 4,902 | +26% | $0 | |
| 2023-10-19 | 2023-10-17 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $375.00 | -243 | 3,901 | -6% | -$91.1K | |
| 2023-10-11 | 2023-10-06 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $360.00 | -242 | 4,144 | -6% | -$87.1K | |
| 2023-08-11 | 2023-08-09 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $345.51 | -242 | 4,386 | -5% | -$83.6K | |
| M | 2023-05-03 | 2023-05-02 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $348.28 | -580 | 4,691 | -11% | -$202.0K |
| 2023-05-03 | 2023-05-01 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +1,168 | 5,208 | +29% | $0 | |
| 2022-10-26 | 2022-10-24 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $310.00 | -621 | 4,040 | -13% | -$192.5K | |
| M | 2022-08-10 | 2022-08-08 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $293.03 | -621 | 4,661 | -12% | -$182.0K |
| M | 2022-08-02 | 2022-07-29 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $278.77 | -621 | 5,604 | -10% | -$173.1K |
| M | 2022-05-04 | 2022-05-02 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale | $258.94 | -737 | 6,320 | -10% | -$190.8K |
| 2022-05-03 | 2022-05-01 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +1,449 | 6,640 | +28% | $0 | |
| D | 2022-04-12 | 2022-04-08 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | S - Sale+OE | $280.20 | -1,907 | 5,191 | -27% | -$534.3K |
| D | 2022-04-12 | 2022-04-08 | VRTX | Vertex Pharmaceuticals | Bhatia Sangeeta N. | Dir | M - OptEx | $125.71 | +1,907 | 7,098 | +37% | +$239.7K |
Purchase Sale Sale after option exercise All abbreviations